Myalgic encephalomyelitis research and treatment

This House commends current research being conducted by the Quadram Institute on the Norwich Research Park that builds on recent evidence that conditions like myalgic encephalomyelitis (ME), and Long Covid, have a basis in the immune system; notes that ME (sometimes known as ME/CFS) is a severely debilitating condition thought to affect up to 250,000 people in the UK and that symptoms include widespread pain, extreme tiredness and an inability to concentrate and that the causes of ME are not known and there are no effective treatments; commends the funding provided by the charity Invest in ME Research to the Quadram Institute to run the only current clinical trial in the UK for ME; believes it is necessary to establish a Centre for ME Research, building on excellent biomedical research, to act as a hub for research and treatment of ME; and calls on the Government to support and promote such a specialist Centre to help develop effective treatments.